vimarsana.com

Latest Breaking News On - Ziegler radiopharma gmbh - Page 1 : vimarsana.com

Eckert & Ziegler Receives Manufacturing Authorization for GMP-grade Lutetium-177

EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word: Miscellaneous Eckert & Ziegler Receives Manufacturing Authorization for GMP-grade Lutetium-177. | April 20, 2023

Eckert & Ziegler Extends Gallium-68 Generator Portfolio in the United States

Eckert & Ziegler Extends Gallium-68 Generator Portfolio in the United States
itnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnonline.com Daily Mail and Mail on Sunday newspapers.

Eckert & Ziegler Radiopharma GmbH: Eckert & Ziegler Extends Gallium-68 Generator Portfolio in the United States

Eckert & Ziegler Radiopharma GmbH: Eckert & Ziegler Extends Gallium-68 Generator Portfolio in the United States
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Eckert & Ziegler Receives Manufacturing Authorization for Thorium and Lutetium Compounds

Eckert & Ziegler Receives Manufacturing Authorization for Thorium and Lutetium Compounds
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Eckert & Ziegler s GalliaPharm distributed by Curium in France

Eckert & Ziegler s GalliaPharm distributed by Curium in France Berlin, Germany and Paris, France, March 01, 2021 (GLOBE NEWSWIRE) Eckert & Ziegler Radiopharma GmbH and Curium PET France have decided to reinforce their existing long term partnership by extending their agreement for the distribution of Galliapharm generators in France, Curium being the partner of choice given the national coverage of its PET network in France . Achieving greater market penetration for our core product GalliaPharm is the focus of our sales strategy. With its established network in France, Curium is thus perfectly qualified to be our partner, Dr. Harald Hasselmann, member of the Executive Board of Eckert & Ziegler AG and responsible for the Medical segment, explained. In the coming years, Gallium-68 based diagnostics will become even more prevalent than today. Eckert & Ziegler is ideally equipped to serve these market needs. Since currently several clinical studies are conducted worldwide wi

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.